Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takeda Finally Reveals €9.6B Nycomed Acquisition; Sheds Dermatology Business, But Otherwise Set On Retention

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Takeda Pharmaceuticals Co. Ltd. finally confirmed it will acquire emerging markets player Nycomed AS. Takeda's initial denial of a $12 billion acquisition proved partially correct, instead agreeing to pay €9.6 billion ($13.7 billion) for the Swiss company, excluding its U.S dermatology business
Advertisement

Related Content

Takeda’s Strategic Run Up To Nycomed
Takeda’s Vaccine Business Aims High, Led By Former Gates Foundation Vaccine Director
Top Japanese Pharmas Show Appetite For Emerging Market Expansion, Will Generics Follow?
Top Japanese Pharmas Show Appetite For Emerging Market Expansion, Will Generics Follow?
Japan's Takeda Reportedly Offering $12B For Europe's Nycomed
Japan's Takeda Reportedly Offering $12B For Europe's Nycomed
Nycomed Expects More Dealmaking in Russia; Prepares Daxas Rollout In Turkey
Nycomed CEO Hakan Bjorklund On Emerging Markets As Core Focus For Growth: An Interview With PharmAsia News
Advertisement
UsernamePublicRestriction

Register

SC077974

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel